| Literature DB >> 28629400 |
Xiaomin Zhang1,2, Qian Du3, Feifei Ma3, Yinglong Lu3, Meiyan Wang4, Xiaorong Li5.
Abstract
BACKGROUND: To describe the characteristics of patients with syphilitic uveitis in northern China.Entities:
Keywords: Neuroretinitis; Posterior placoid chorioretinitis; Pseudoretinitis pigmentosa; Syphilitic uveitis; chorioretinitis
Mesh:
Year: 2017 PMID: 28629400 PMCID: PMC5477137 DOI: 10.1186/s12886-017-0491-6
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Classification of posterior syphilitic uveitis
| Pattern | Description |
|---|---|
| Chorioretinitis | The inflammation of the choroid, retinal pigment epithelium and retina, with change of choroid perfusion, pigment epitheliopathy and retinal hyperfluorescence in fluorescein. |
| Neuroretinitis | The inflammation is confined to both retina and papilla optica. |
| Retinitis | The inflammation is confined to retina. |
| papillitis | The inflammation mainly affects papilla optica. |
| Primary retinal vasculitis | The inflammation mainly affects the retinal vessels. |
| Posterior placoid chorioretinitis | Fundus shows a yellowish, placoid, outer retinal lesion, involving the macular, with hyperfluorescence in the area of the lesion in fluorescein. |
Summary of demographic and clinical history of syphilitic patients (n = 21)
| Demographic and clinical history | No. (%) of patients |
|---|---|
| Gender | |
| Male | 8 (38.1%) |
| Female | 13 (61.9%) |
| Clinical findings | |
| Systemic and ocular syphilis | 13 (61.9%) |
| Ocular syphilis only | 9 (42.9%) |
| Evidence of neurosyphilis | 2 (9.5%) |
| Diagnosis of syphilis | |
| Known case | 3 (14.3%) |
| Male | 2 (9.5%) |
| Female | 1 (4.8%) |
| Diagnosed after presentation | 18 (85.7%) |
| Male | 6 (28.6%) |
| Female | 12 (57.1%) |
| Stages | |
| Primary syphilis | 0 |
| Secondary syphilis | 9 (42.9%) |
| Latent syphilis | 10 (47.6%) |
| Tertiary syphilis | 2 (9.5%) |
| Duration | |
| ≥ 6 months | 10 (47.6%) |
| 9 (42.9%) | |
| 2 (9.5%) | |
| ≤ 1 month; < 6 months | |
| < 1 month | 9 (42.9%) |
| 12 (57.1%) | |
| Eyes involved | |
| Unilateral | 13 (61.9%) |
| Bilateral | 8 (38.1%) |
| Previous diagnosis | |
| Misdiagnosed | 7 (33.3%) |
| Undiagnosed | 3 (14.3%) |
| Usage of systemic immunosuppressants | 1 (4.8%) |
| ≥ 2 months | 10 (47.6%) |
| ≤ 0.5 month; < 2 months | |
| < 0.5 month | |
| Without systemic therapy | |
Fig. 1Typical fundus photographs and fluorescein angiographies. a diffuse chorioretinitis with multiple white-yellow punctuate nodules on the retina; b neuroretinitis; c vasculitis; d severe vitreous haze and multiple mutton fat-like inner precipitates; e severe vitreous haze and white-yellowish masses attached to the peripheral posterior vitreous membrane; f severe vitreous haze and vitreous hemorrhage
Fig. 2Typical pictures of macular changes. a cystoid macular edema; b epiretinal membrane; c disappear of the photoreceptor inner segment-outer segment junction line; d choroidal neovascularization
Fig. 3Fundus manifestations of posterior placoid chorioretinitis. a fundus photograph of the left eye of patient 5; b autofluorescence image of the left eye of patient 5; c fluorescein angiography of the left eye of patient 5; d fundus photograph of the right eye of patient 5; e autofluorescence image of the right eye of patient 5; f fluorescein angiography of the right eye of patient 5; g fundus photograph of the right eye of patient 19; h fluorescein angiography of the right eye of patient 19; i: fundus photograph of the right eye of patient 17 taken two months ago before visiting our department
Summary of clinical characteristics of eyes with syphilitic uveitis (n = 33)
| Clinical characteristics | No. (%) of eyes |
|---|---|
| Presenting complaint | |
| Blurring of vision | 31 (93.9%) |
| Floaters | 14 (42.4%) |
| Redness | 11 (33.3%) |
| Pain | 7 (21.2%) |
| Photopsia | 7 (21.2%) |
| Initial BCVA | |
| ≥ 20/40 | 9 (27.3%) |
| 20/50–20/200 | 14 (42.4%) |
| < 20/200 | 10 (30.3%) |
| Final BCVA | |
| ≥ 20/40 | 21 (63.6%) |
| 20/50–20/200 | 11 (33.3%) |
| < 20/200 | 1 (3.0%) |
| Improved | 27 (81.8%) |
| Unchanged | 7 (21.2%) |
| worsen | 1 (3.0%) |
| Type of uveitis | |
| Anterior uveitis | 0 |
| Intermediate uveitis | 1 (3.0%) |
| Posterior uveitis | 19 (57.6%) |
| Panuvetiis | 13 (39.4%) |
| Granulomatous | 1 (3.0%) |
| Nongranulomatous | 12 (36.4%) |
| Ocular signs | |
| Episcleritis | 1 (3.0%) |
| Hypopyon | 2 (6.1%) |
| Posterior synechiae | 1 (3.0%) |
| Vitreous haze | 13 (39.4%) |
| Chorioretinitis | 19 (57.6%) |
| Neuroretinitis | 7 (21.2%) |
| Papilitis | 2 (6.1%) |
| Vasculitis | 3 (9.1%) |
| Posterior placoid chorioretinits | 3 (9.1%) |
| Pseudoretinitis pigmentosa | 11 (33.3%) |
| Retinal or vitreous hemorrhage | 3 (9.1%) |
| Vascular occlusion | 2 (6.1%) |
| Inner precipitates | 2 (6.1%) |
| White-yellow punctuate nodules | 1 (3.0%) |
| Patchy white-yellow lesions | 1 (3.0%) |
| Cystoid macular edema | 6 (18.2%) |
| Epiretinal membrane | 4 (12.1%) |
Note. BCVA best-corrected visual acuity
Ocular signs and duration of disease (n = 33)
| Ocular signs | Duration (month) | ||
|---|---|---|---|
| Range/mean | No. (%) of eyes | ||
| < 6 months | ≥ 6 months | ||
| Vitreous haze | 0.2–12/3.2 | 9 (27.3%) | 4 (12.1%) |
| Choroidretinitis | 1–24/7.3 | 5 (15.2%) | 14 (42.4%) |
| Neuroretinitis | 0.2–2/1.3 | 7 (21.2%) | 0 |
| Posterior placoid chorioretinits | 1–2/1.3 | 3 (9.1%) | 0 |
| Pseudoretinitis pigmentosa | 6–24/9.6 | 0 | 11 (33.3%) |
| Cystoid macular edema | 2–12/10.0 | 1 (3.0%) | 5 (15.2%) |
| Epiretinal membrane | 6–12/9 | 0 | 4 (12.1%) |
Fig. 4Typical pictures of pseudoretinitis pigmentosa. The fundus photograph, fluorescein angiography, optical coherence tomography, and visual field of patient 4 (a-d) and 6 (e-h)
Associations of factors (dichotomous variable) with the final BCVA in univariate analyses
| Variables | n | x ± s | t | p | |
|---|---|---|---|---|---|
| Gender | Male | 13 | 0.685 ± 0.339 | 1.059 | 0.298 |
| Female | 20 | 0.561 ± 0.320 | |||
| Eye | OD | 19 | 0.564 ± 0.313 | −0.925 | 0.362 |
| OS | 14 | 0.671 ± 0.350 | |||
| Systemic immunosuppressive therapy | Yes | 14 | 0.457 ± 0.293 | −2.467 | 0.019 |
| No | 19 | 0.722 ± 0.313 | |||
Eye based analysis (n = 33)
Associations of factors (continuous variables) with the final BCVA in univariate analyses
| Variables | r | p |
|---|---|---|
| Duration | −0.518a | 0.002 |
| Age | −0.512b | 0.002 |
| Initial BCVA | 0.640b | <0.001 |
Note. BCVA best-corrected visual acuity, aSpearman’s rank correlation was used, bPearson linear correlation was used
Eye based analysis (n = 33)
Factors significantly associated with the final BCVA in multiple linear regression models
| Variables | β | Stβ | t | p |
|---|---|---|---|---|
| Constant | 0.505 | — | 6.246 | <0.001 |
| Duration | 0.621 | 0.576 | 4.399 | <0.001 |
| Initial BCVA | −0.020 | −0.316 | −2.413 | 0.022 |
Note. BCVA best-corrected visual acuity
Eye based analysis (n = 33)